Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques.
about
Standardization of NAT for Blood-Borne PathogensDifferences between Two Real-Time PCR-Based Hepatitis C Virus (HCV) Assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and One Signal Amplification Assay (Versant HCV RNA 3.0) for RNA Detection and QuantificationInternational standards and reference materials for quantitative molecular infectious disease testing.Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells.High-sensitivity PCR detection of parvovirus B19 in plasmaParvovirus B19 - Revised.Nucleic acid amplification technology methods used in blood donor screening.Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors.Establishment of the 1st World Health Organization International Standard for Plasmodium falciparum DNA for nucleic acid amplification technique (NAT)-based assays.Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays.A significantly lower potency observed for the 3rd WHO International Standard for Parvovirus B19V DNA with the cobas TaqScreen DPX test.Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests.Evaluation of a real-time PCR assay using the LightCycler system for detection of parvovirus B19 DNA.Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples.Genome sequences of parvovirus b19 reference strains.Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus.Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors.Evaluation of two, commercial, multi-dye, nucleic acid amplification technology tests, for HBV/HCV/HIV-1/HIV-2 and B19V/HAV, for screening blood and plasma for further manufacture.Sensitivity of HCV RNA and HIV RNA blood screening assays.Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors.Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.A World Health Organization International Standard for hepatitis A virus RNA nucleic acid amplification technology assays.Parvovirus B19 transmission by a high-purity factor VIII concentrate.Parvovirus B19: What Is the Relevance in Transfusion Medicine?Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins.Parvovirus B19 DNA in Factor VIII concentrates: effects of manufacturing procedures and B19 screening by nucleic acid testing.
P2860
Q26777738-1308D291-370F-49D6-828D-878B5A4CA67DQ27487396-ED48BA9B-5F34-4399-B41B-65ABE91C65D6Q33856184-5AC5C93C-29BB-4B17-BF96-BA462780FD22Q34124006-53992726-C909-4138-B547-7EAA3830FCF9Q34196699-9BDCB1AA-422E-4653-9AC3-44DD0B60BDA4Q34625443-EB23F4B3-05BA-4C1D-A0B7-B4C3A637C2FCQ34830170-09A5F09C-EA8A-41A5-96BF-1E52A737AFD2Q36665779-FD819CEB-ACC1-4C6C-9716-97CF906DFCADQ36841543-E9FA769E-AE1E-47FD-822D-EF61FA6EE8DDQ36845374-151D5B71-A773-4ACA-9005-5B9F53193DFFQ40686343-7B170DE5-9103-4E28-AE1F-37AAD76D54C8Q40834278-C3112A96-5CD7-4A1F-A854-29EE28A3B41AQ41039842-B87ACAD8-A599-4D19-9249-A3FCC1BA83A9Q41294587-32678C2F-AA2D-473D-90E3-9D075F699972Q41707178-B4CD5410-06A3-44F4-9BF5-87A1F094E18AQ41913573-F02EB8F7-7A64-49E4-A49C-938252A26905Q42181383-FA09A209-25AA-4700-847C-507252970BEDQ42987407-1AFEC6CD-F34F-4FEF-8669-AC2315E33E30Q43038525-3E851B41-A768-4358-A55B-7751ABF1F6C1Q44082333-21C81EBF-E2BC-4DE6-8C0C-BC98587B8CCBQ45377713-B1901868-ED98-4B87-8F73-E0A923CAF788Q45452599-12B00E7B-9DA7-4054-807B-A3BECEFCDB33Q47786736-5E6FBEAC-663C-4CB0-96C2-77DF36D326D6Q49416500-66EA66E3-BAD8-4CF8-AF1A-CC570DBA1128Q52016510-F506965A-DB93-4B8A-89B5-02E36E54CA71Q53237311-0A04B8B6-EBA6-48F9-BD2C-7C5371C060BF
P2860
Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Establishment of the first Wor ...... acid amplification techniques.
@en
Establishment of the first Wor ...... acid amplification techniques.
@nl
type
label
Establishment of the first Wor ...... acid amplification techniques.
@en
Establishment of the first Wor ...... acid amplification techniques.
@nl
prefLabel
Establishment of the first Wor ...... acid amplification techniques.
@en
Establishment of the first Wor ...... acid amplification techniques.
@nl
P2093
P2860
P1433
P1476
Establishment of the first Wor ...... acid amplification techniques.
@en
P2093
B19 Collaborative Study Group
J Saldanha
P2860
P356
10.1046/J.1423-0410.2002.00132.X
P577
2002-01-01T00:00:00Z